rethinkPeptides Search
Menu
RethinkPeptides

GLP-1 Kidney Effects

Explore peptide research and guides on glp-1 kidney effects.

GLP-1 Kidney Effects

GLP-1 Agonists and Kidney Disease Protection

The FLOW trial proved semaglutide reduces major kidney events by 24% in diabetic CKD. How GLP-1 agonists protect kidneys through multiple mechanisms.

GLP-1 Kidney Effects

GLP-1 Drugs and Albuminuria: The Kidney Leak

GLP-1 receptor agonists reduce albuminuria by 16-39% across trials. How these drugs lower urine albumin and what it means for kidney disease progression.